MRNA May 2024 127.000 put
| Previous close | 0.0400 |
| Open | 0.0200 |
| Bid | 0.0000 |
| Ask | 0.0100 |
| Strike | 127.00 |
| Expiry date | 2024-05-31 |
| Day's range | 0.0100 - 0.6500 |
| Contract range | N/A |
| Volume | |
| Open interest | 310 |
- Yahoo Finance Video
FDA considers updating COVID boosters, Novavax stock reacts
The US Food and Drug Administration (FDA) is set to vote on recommendations for updated COVID-19 booster shots as the KP.2 variant strain begins to spread across the US. Yahoo Finance Health Reporter Anjalee Khemlani joins Market Domination to discuss the impact this is having on vaccine makers, particularly Novavax (NVAX), whose stock has shot up in Monday's session. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.
Insider MonkeyIs Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Moderna, Inc. (NASDAQ:MRNA) is the top gene therapy stock to invest in now. Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease. This approach […]
Investor's Business DailyModerna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.
